DLX6
Homeobox protein DLX-6
Also known as: DLX6_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P56179
- Gene
- DLX6
- Ensembl
- ENSG00000006377
- Chromosome
- 7
- Canonical length
- 175 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nuclear bodies
OverviewNCBI Gene
This gene encodes a member of a homeobox transcription factor gene family similiar to the Drosophila distal-less gene. This family is comprised of at least 6 different members that encode proteins with roles in forebrain and craniofacial development. This gene is in a tail-to-tail configuration with another member of the family on the long arm of chromosome 7. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
175 residues, UniProt reviewed canonical sequence.
>P56179|DLX6
1 MSHSQHSPYL QSYHNSSAAA QTRGDDTDQQ KTTVIENGEI RFNGKGKKIR KPRTIYSSLQ
61 LQALNHRFQQ TQYLALPERA ELAASLGLTQ TQVKIWFQNK RSKFKKLLKQ GSNPHESDPL
121 QGSAALSPRS PALPPVWDVS ASAKGVSMPP NSYMPGYSHW YSSPHQDTMQ RPQMMLocalizationUniProt · AlphaFold · HPA
Whether an antibody against DLX6 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.6
- Highest tissue expression
- 10 nTPM
Expression across tissuesHPA
Tissue
- basal ganglia: 10 nTPM
- testis: 5.2 nTPM
- hypothalamus: 3.6 nTPM
- placenta: 2.8 nTPM
- endometrium: 2.4 nTPM
- cervix: 1.9 nTPM
Single-cell type
- extravillous trophoblasts: 97 nCPM
- oocytes: 65 nCPM
- migrating cytotrophoblasts: 45 nCPM
- cytotrophoblasts: 38 nCPM
- endometrial luminal cells: 38 nCPM
- endometrial ciliated cells: 34 nCPM
Immune cell
- basophil: 0.1 nTPM
- neutrophil: 0.1 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- basal ganglia: 17 nTPM
- hypothalamus: 12 nTPM
- cerebral cortex: 7.6 nTPM
- amygdala: 5.1 nTPM
- thalamus: 3.4 nTPM
- hippocampal formation: 2.2 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.38
- gnomAD pLI
- 0.92
- gnomAD missense Z
- 1.17
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- anatomical structure formation involved in morphogenesis
- cell differentiation
- embryonic limb morphogenesis
- embryonic skeletal system development
- epithelial cell differentiation
- head development
- inner ear morphogenesis
- nervous system development
- positive regulation of epithelial cell proliferation
- regulation of transcription by RNA polymerase II
- roof of mouth development
- skeletal system development
Molecular functions
- DNA-binding transcription factor activity
- DNA-binding transcription factor activity, RNA polymerase II-specific
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- sequence-specific double-stranded DNA binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads DLX6 as an antibody target. Whether an autoantibody or antibody against DLX6 could matter depends on whether native DLX6 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
DLX6 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label DLX6 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...